BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Tencent Invests US$30 Million in Hong Kong’s Insighta, Valuing the Early Cancer Detection Company at US$200 Million

Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, announced that Tencent has made a strategic US$30 million&n...

October 16, 2024 | News

Genentech's Itovebi™ Wins FDA Approval for HR-Positive Breast Cancer, Doubling Progression-Free Survival in PIK3CA-Mutated Cases

– Approval is based on Phase III INAVO120 results, showing the ItovebiTM (inavolisib)-based regimen more than doubled progression-free sur...

October 11, 2024 | News

Arbele Announces Strategic Collaborations to Advance AI-Driven Precision Oncology and Immunotherapeutics Development

Arbele, a leading innovator in biopharmaceutical & biotechnology focused on targeting cadherin-17 (CDH17), is pleased to announce strategic collaborati...

October 10, 2024 | News

Arcus and AstraZeneca Partner to Evaluate Novel Combination Therapy for Advanced Renal Cell Carcinoma

Arcus and AstraZeneca to evaluate their respective molecules in combination to establish a potential first- and best-in-class treatment for clear c...

October 03, 2024 | News

NUS Researchers Introduce TETRIS Technology to Transform Cancer Diagnostics and Personalized Treatment

Scalable and adaptable, TETRIS captures the diversity of protein interactions on site to inform accurate cancer diagnoses, enabling the personalisation of ...

October 01, 2024 | News

Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals

The Hong Kong Breast Cancer Registry (HKBCR), run by the Hong Kong Breast Cancer Foundation (HKBCF), launched its 16th annual research report&nbs...

September 30, 2024 | News

Anbogen Partners with BeiGene to Launch Global Phase II Trial for Innovative Colorectal Cancer Treatment

Anbogen, a clinical-stage biotech company, announced a drug supply collaboration to evaluate the combination of Anbogen's HDAC inhibitor, ABT-301, with Bei...

September 30, 2024 | News

BioCina Partners with EnGeneIC to Accelerate Manufacturing of Cutting-Edge Cancer Treatment

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with drug deve...

September 25, 2024 | News

The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia

This is especially concerning in Asia, where rates of illness are expected to rise in the coming years. When it comes to breast cancer, for instance, Asia ...

September 20, 2024 | Opinion | By Deepti Saraf General Manager, Roche (Malaysia) Sdn. Bhd.

Full-Life Technologies Secures $571.5M Licensing Deal with SK Biopharmaceuticals for Anti-Cancer Radiopharmaceutical FL-091

Full-Life Technologies seals $571.5 million agreement with SK Biopharmaceuticals to license and further develop Full-Life's 'FL-091' ra...

September 19, 2024 | News

Massive Bio Launches Free AI-Powered Portal to Simplify Cancer Clinical Trial Enrollment for Patients Worldwide

Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovati...

September 17, 2024 | News

Johnson & Johnson’s TAR-200 Shows Promising Results in BCG-Unresponsive Bladder Cancer in Latest Phase 2b SunRISe-1 Study

Johnson & Johnson announced additional results from its pivotal Phase 2b SunRISe-1 study, reinforcing the safety and efficacy of TAR-200, an investigat...

September 16, 2024 | News

Qritive Partners with Roche to Transform Cancer Diagnostics with AI-Powered Pathology Solutions

Qritive, a leading digital pathology and AI company headquartered in Singapore, is proud to announce its collaboration with Roche, one of the largest ...

September 13, 2024 | News

GC Cell Partners with Indonesia’s Bifarma in Major Technology Transfer for Immuncell-LC Cancer Therapy

GC Cell, a leading innovator in cell therapy, has officially announced the execution of a landmark 'Technology Transfer and License Agreement' with PT Bifa...

September 11, 2024 | News

Stay Connected